Lupus nephritis cost-effectiveness of therapy: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(3 intermediate revisions by 2 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Lupus nephritis}}
{{Lupus nephritis}}
{{CMG}}
{{CMG}} {{AE}} {{OK}}


==Overview==
==Overview==

Latest revision as of 16:26, 26 October 2018

Lupus nephritis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Lupus nephritis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Lupus nephritis cost-effectiveness of therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Lupus nephritis cost-effectiveness of therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Lupus nephritis cost-effectiveness of therapy

CDC on Lupus nephritis cost-effectiveness of therapy

Lupus nephritis cost-effectiveness of therapy in the news

Blogs on Lupus nephritis cost-effectiveness of therapy

Directions to Hospitals Treating Lupus nephritis

Risk calculators and risk factors for Lupus nephritis cost-effectiveness of therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Omer Kamal, M.D.[2]

Overview

For more information:

Systemic lupus erythematosus cost-effectiveness of therapy

References

Template:WH Template:WS